Science

Power Hour Breakout

G5 — The Impact of Blood Culture Contamination on Patient Safety, Clinical Outcomes and Hospital Reimbursement

Sunday, September 16
3:45 PM - 4:45 PM
Location: C150
Presentation CE Credits: 1

This presentation hopes to expand the vascular access clinician’s knowledge of a serious medical problem--contaminated blood cultures and the misdiagnosis of sepsis. Inaccurate diagnosis of a blood culture can increase the patient's risk of antibiotic resistant infections, including MRSA, VRE and Clostridium difficile. Other negative outcomes include unnecessary false-positive CLABSI reporting and extended length-of-stay and associated problems, such as HACs/HAIs.

False positive blood cultures also have hospital-associated consequences such as increased costs for patient admissions, many of which are non-reimbursable. Methods for driving antibiotic stewardship and reduction of antibiotic usage is necessary for hospitals who are critically looking at quality outcomes. The impact of blood culture contamination directly impacts key CMS quality outcome metrics (complications, readmissions, length of stay, and patient experience/HCAHPS) which dictate hospital reimbursement.


 



Contaminated blood cultures are a severe problem for patients and hospitals. With current best practices, can we achieve the goal of "zero?" It may be possible!

Learning Objectives:

ViewAttendees 38 Audio Slides

Cheryl Kelley, RN, BSN, VA-BC™

Clinical Operations Manager
Magnolia Medical Technologies, Inc.

Cheryl is a nationally recognized clinical nurse consultant who focuses in vascular access and infusion therapy. She is an expert in venous access for central and peripheral access and has extensive experience in both clinical and manufacturing arenas. She was employed at West Virginia University for 25 years with 10years on the vascular access/PICC team. Since 2007, she has been employed in the medical device industry as both a clinical specialist and clinical marketing manager. Cheryl presently is Clinical Operations Manager for Magnolia Medical Technologies.

Presentation(s):

ViewAttendees 38 Audio Slides

Send Email for Cheryl Kelley


Assets

G5 — The Impact of Blood Culture Contamination on Patient Safety, Clinical Outcomes and Hospital Reimbursement

Audio Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for The Impact of Blood Culture Contamination on Patient Safety, Clinical Outcomes and Hospital Reimbursement